sr141716 has been researched along with Hepatitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hassan, R; Mahmoud, MF; Rezq, S | 1 |
1 other study(ies) available for sr141716 and Hepatitis
Article | Year |
---|---|
Rimonabant ameliorates hepatic ischemia/reperfusion injury in rats: Involvement of autophagy via modulating ERK- and PI3K/AKT-mTOR pathways.
Topics: Animals; Autophagy; Autophagy-Related Proteins; Cannabinoid Receptor Antagonists; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Hepatitis; Inflammation Mediators; Lipid Peroxidation; Liver; Liver Cirrhosis; Male; Oxidative Stress; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Wistar; Receptor, Cannabinoid, CB1; Reperfusion Injury; Rimonabant; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |